UPDATE 2-Stryker profit beats, but hip and knee sales weak

7 million, or 80 cents a share, a year ago, due to charges related to the acquisition of Boston Scientific Corp's BSX.N neurovascular division. Excluding those charges, Kalamazoo, Michigan-based Stryker earned 90 cents a share, up from 80 cents a share...